Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5624008 | Alzheimer's & Dementia | 2015 | 10 Pages |
IntroductionIt is unclear whether white matter hyperintensities (WMHs), magnetic resonance imaging markers of small-vessel cerebrovascular disease, promote neurodegeneration and associated clinical decline in Alzheimer's disease (AD), or simply co-occur with recognized pathogenic processes.MethodsIn 169 patients with mild cognitive impairment, followed for 3Â years, we examined the association of (1) baseline regional WMH and cerebral spinal fluid-derived t-tau (total tau) with entorhinal cortex atrophy rates, as a marker of AD-related neurodegeneration, and conversion to AD; and (2) baseline regional WMH with change in t-tau level.ResultsIn participants with low baseline t-tau, higher regional WMH volumes were associated with faster entorhinal cortex atrophy. Higher parietal WMH volume predicted conversion to AD in those with high t-tau. Higher parietal and occipital WMH volumes predicted increasing t-tau.DiscussionWMHs affect AD clinical and pathologic processes both directly and interacting with tau.